Exact Sciences Announces Second Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Exact Sciences (EXAS) Misses Q2 EPS by 27c, Revenue Beats
July 28, 2021 4:09 PM EDTExact Sciences (NASDAQ: EXAS) reported Q2 EPS of ($1.03), $0.27 worse than the analyst estimate of ($0.76). Revenue for the quarter came in at $434.8 million versus the consensus estimate of $421.28 million.
GUIDANCE:
Exact Sciences sees FY2021 revenue of $1.71-1.75 billion, versus the consensus of $1.72... More
